查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1722404

2025 年至 2033 年放射腫瘤學市場報告（按類型、技術、應用、最終用戶和地區）

Radiation Oncology Market Report by Type, Technology, Application, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 137 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球放射腫瘤學市場規模達 86 億美元。展望未來， IMARC Group預計到 2033 年市場規模將達到 149 億美元，2025-2033 年期間的成長率 (CAGR) 為 6.3%。技術進步、癌症發生率上升、對腫瘤放射認知的提高、政府舉措和合作、新療法的監管批准以及個人化醫療的趨勢是促進市場成長的一些因素。

放射腫瘤學市場分析：

主要市場促進因素：放射腫瘤學市場的成長受到多種因素的推動，包括全球癌症發生率的激增。對有效和準確的治療方法的高需求促使影像引導放射治療和質子治療的發展，這進一步刺激了市場成長。另一個趨勢是老年人口數量的增加，從統計數據來看老年人口更容易罹患癌症。此外，對醫療中心發展的投資（特別是在發展中國家）以及政府和私人癌症篩檢和預防措施的實施正在推動放射腫瘤學市場佔有率的成長。與此相符的是，研究機構和公司正在積極聯手開發創新放射療法，這有利於市場成長。

主要市場趨勢：放射腫瘤學市場的主要趨勢之一是向低分次和超低分次療法轉變，即在幾個療程中給予更高劑量的放射線。這種方式方便了患者，也減少了醫療支出。此外，人工智慧 (AI) 和機器學習 (ML) 在治療計劃系統中的使用正在成長，產生了更量身定做的管理模式，與傳統系統相比，可以更精確地將輻射傳送到受影響的位置，同時減少對周圍健康組織的損害，從而加速市場成長。此外，多模態治療繼續帶來福音，將放射療法與手術、化療和免疫療法等其他療法結合，進一步改善治療效果。除此之外，治療計劃的日益成長的趨勢正在推動放射腫瘤學市場的成長，該趨勢旨在最大限度地減少治療對患者生活品質的影響。

地理趨勢：目前，北美處於世界放射腫瘤學市場的前沿。該地區佔據主導地位的因素有很多，包括先進的醫療保健基礎設施、高額的醫療保健支出以及知名設備製造商的存在。該地區強大的市場地位也源於積極的研究和高新技術採用率，例如質子治療中心。此外，歐洲市場的擴張受到嚴格的醫療政策和大規模公共衛生計劃的推動，這些政策和計劃強調癌症治療品質和可近性的重要性。根據放射腫瘤學市場分析，亞太地區是一個新興地區。醫療保健支出不斷增加，人們對癌症的認知也日益增強。中國和印度等國家的醫療設施正變得越來越先進。

競爭格局：市場競爭格局的特徵是主要放射腫瘤學公司的存在，例如 Accuray Incorporated、Becton Dickinson and Company、Canon Inc.、Elekta、Hitachi Ltd.、Icad Inc.、Ion Beam Applications、Isoray Inc.、Mevion Medical Systems Inc.、Nevordion (Ion Beam Applications、Isoray Inc.、Mjion Medical Systems Inc.、Nevordion (Siada) Inc. AG)、ViewRay 等。

挑戰與機會：放射腫瘤學市場面臨先進放射治療系統相關成本高昂等挑戰，可能限制欠富裕地區的市場滲透。監管障礙也帶來了重大挑戰，因為獲得新技術的批准可能既費時又昂貴。此外，新興市場缺乏熟練的專業人員，這阻礙了先進療法的採用。然而，這些挑戰也帶來了機會。例如，開發具有成本效益的放射治療機可以幫助滲透低收入市場。針對腫瘤護理提供者的教育措施和培訓計劃可以緩解合格專業人員的短缺。

放射腫瘤學市場趨勢：

技術進步

影響全球放射腫瘤學市場的主要因素之一是不斷進步的技術。包括調強放射治療 (IMRT) 和影像導引放射治療 (IGRT) 在內的技術發展重新定義了癌症的治療，能夠更準確地瞄準腫瘤，同時最大程度地減少對其他健康身體細胞的損害。例如，IMRT 所施加的輻射劑量具有不同的強度。該技術使腫瘤科醫師能夠根據腫瘤的複雜形狀調整放射束，同時盡量減少對周圍健康組織的破壞。另一方面，IGRT 利用 CT 掃描或 MRI 等專門的影像技術在每次治療前確定腫瘤的確切位置。除了產生高品質的腫瘤影像外，IGRT 還提供測試位置驗證和執行多條機械化輻射束的治療。此外，橫向治療的進步導致了質子治療的發明。該療法使用高能量質子取代傳統的X光進行放射治療，可以實現更高的劑量集中度，同時將副作用降至最低。例如，2024年，一個主要來自核武相關科學機構的中國研究小組設計了一種名為「閃光」的強力輻照系統。該系統能夠施加超高能量輻射，並有可能改變傳統的放射療法。

癌症發生率上升

全球放射腫瘤學市場主要受到世界各地癌症發生率增加的推動，尤其是在發展中國家。根據世界衛生組織（WHO）最新的全球癌症發生率報告，2022年印度新增癌症病例超過141萬例，癌症死亡人數超過91萬例。乳癌是全球最常見的癌症發生率指標，佔所有新發癌症的十分之一以上。隨著年齡的成長，癌症的發生率也會上升；此外，長期已知的機會的變化和長期存在的環境因素也是額外的成長因素。癌症患者數量的不斷成長也推動了放射腫瘤學的需求，預計癌症將成為國際上最常見的死亡原因之一。

提高意識和政府舉措

對早期癌症診斷和治療重要性的認知不斷提高，以及公共部門積極主動地分配資源以確保癌症患者得到高品質的護理，正在推動全球放射腫瘤學的發展。各種非政府組織 (NGO) 和國際組織正在實施多項公眾意識計劃和活動，以提高患者對癌症和放射治療服務日益成長的需求的認知。政府衛生機構也正在投資癌症控制、設施開發和支付計劃，以增強獲得放射服務的機會並減輕癌症負擔，這進一步推動了放射腫瘤學市場前景。

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球放射腫瘤學市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場細分：依類型

  • 體外放射治療
    • 關鍵部分
      • 直線加速器
      • 緊湊型先進放射治療系統
      • 質子治療
  • 內照射放射治療
    • 關鍵部分
      • 近距離放射治療
      • 全身放射治療
      • 其他

第7章：市場區隔：依技術

  • 影像導引放射治療 (IGRT)
  • 調強放射治療 (IMRT)
  • 立體定位技術
  • 質子束治療
  • 3D適形放射治療（3D CRT）
  • 容積調強弧形治療 (VMAT)
  • 近距離放射治療

第 8 章：市場區隔：按應用

  • 攝護腺癌
  • 乳癌
  • 肺癌
  • 頭頸癌
  • 大腸直腸癌
  • 婦科癌症
  • 子宮頸癌
  • 陰莖癌
  • 其他

第9章：市場區隔：依最終用戶

  • 醫院
  • 癌症研究機構
  • 門診及放射治療中心

第10章：市場細分：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第 15 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Accuray Incorporated
    • Becton Dickinson and Company
    • Canon Inc.
    • Elekta
    • Hitachi Ltd.
    • Icad Inc.
    • Ion Beam Applications
    • Isoray Inc.
    • Mevion Medical Systems Inc.
    • Nordion (Canada) Inc. (Sotera Health)
    • P-Cure Ltd.
    • Varian Medical Systems Inc. (Siemens Healthineers AG)
    • ViewRay
Product Code: SR112025A5805

The global radiation oncology market size reached USD 8.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 14.9 Billion by 2033, exhibiting a growth rate (CAGR) of 6.3% during 2025-2033. Technological advancements, rising cancer incidence, increasing awareness regarding oncology radiation, government initiatives, and collaborations, regulatory approvals for new therapies, and the trend towards personalized medicine are some of the factors fostering the market growth.

Radiation Oncology Market Analysis:

Major Market Drivers: The radiation oncology market growth is fueled by the factors, including the surging prevalence of cancer across the globe. The high demand for effective and accurate treatment methods prompts the development of image-guided radiation therapy and proton therapy, which is further stimulating the market growth. Another trend is also the rise in the number of geriatric population that is statistically more prone to cancer. In addition, investments in the development of medical centers, especially in developing countries, and availability of government and private cancer screening and prevention initiatives are driving the radiation oncology market share. In line with this, research institutions and companies are actively joining forces for the development of innovative radiation therapies, which is favoring the market growth.

Key Market Trends: One of the key radiation oncology market trends is the shift toward hypofractionated and ultra-hypofractionated therapies, in which higher doses of radiation are given over few sessions. This approach is convenient for patients and reduces medical expenditures. Moreover, the use of artificial intelligence (AI) and machine learning (ML) in treatment planning systems is growing, producing more tailored administration patterns which deliver radiation more precisely to the affected location than traditional systems while reducing damage to surrounding healthy tissue, which is accelerating the market growth. Furthermore, multimodality treatments continue to provide a boon, combining radiation therapy with other treatments like surgery, chemotherapy, and immunotherapy, which further improves therapeutic outcomes. Apart from this, the growing trend towards therapeutic scheduling that minimizes the impact of the therapy on the patient's quality of life is driving the radiation oncology market growth.

Geographical Trends: At present, North America is at the forefront of the world's radiation oncology market. Several factors contribute to this region's dominance, including the advanced healthcare infrastructure, high healthcare spending, and the presence of prominent device manufacturers. The region's strong market position also stems from research being pursued aggressively and high rates of new technology adoption, such as proton therapy centers. Moreover, Europe's market expansion is driven by stringent healthcare policies and large-scale public health programs that stress the importance of cancer treatment quality and accessibility. As per the radiation oncology market analysis, the Asia-Pacific is an up-and-coming region. Healthcare spending is on the rise, and cancer awareness is growing. The healthcare facilities are becoming more advanced in countries such as China and India.

Competitive Landscape: The competitive landscape of the market is characterized by the presence of key radiation oncology companies, such as Accuray Incorporated, Becton Dickinson and Company, Canon Inc., Elekta, Hitachi Ltd., Icad Inc., Ion Beam Applications, Isoray Inc., Mevion Medical Systems Inc., Nordion (Canada) Inc. (Sotera Health), P-Cure Ltd., Varian Medical Systems Inc. (Siemens Healthineers AG), ViewRay, etc.

Challenges and Opportunities: The radiation oncology market faces challenges such as high costs associated with advanced radiation therapy systems, which can limit market penetration in less affluent regions. Regulatory hurdles also pose significant challenges, as gaining approval for new technologies can be time-consuming and costly. Moreover, there is a shortage of skilled professionals in emerging markets, which hampers the adoption of advanced therapies. However, these challenges also present opportunities. For example, the development of cost-effective radiation therapy machines can help penetrate low-income markets. Educational initiatives and training programs for oncology care providers can alleviate the shortage of qualified professionals.

Radiation Oncology Market Trends:

Technological Advancements

One of the major factors influencing the global radiation oncology market is the continually advancing technology. Technological development, including the creation of intensity modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT), have redefined the treatment of cancer, enabling more accurate targeting of tumors with minimal damage to other healthy body cells. For example, IMRT employs varied intensities in the radiation doses it administers. This technology enables oncologists to conform the radiation beams according to the complicated shape of the tumor with minimal destruction of surrounding healthy tissues. IGRT, on the other hand, utilizes specialized imagining such as CT scans or MRIs to identify the tumor's exact location before each treatment session. In addition to producing high quality images of the tumor, IGRT offers test position verification and treatment carrying out several mechanized radiation beams. Further, lateral therapy advancements have resulted in the invention of proton therapy. This therapy administers radiation with high-energy protons instead of traditional x-rays, allowing superior dose concentration with minimal side effects. For instance, in 2024, a powerful irradiation system called the Flash was designed by a Chinese research group mainly from nuclear weapons related scientific institutions. The system is capable of administering ultra-high energy radiation and has the potential to transform conventional radiotherapy.

Rising Incidence of Cancer

The global radiation oncology market is primarily fueled by an increase in cancer occurrence across the world, mainly in developing countries. According to the most recent report on the global occurrence of the disease by the World Health Organization (WHO), there were over 14.1 lakh new cancer instances and more than 9.1 lakh cancer-related deaths in India in 2022. Breast cancer was the most frequently identified measure of global occurrence of the disease, accounting for more than one-tenth of all new illnesses. The prevalence of cancer rises as people age; moreover, a change in long-known chances and the presence of longstanding environmental are additional growth factors. The radiation oncology demand is also boosted by the growing number of cancer patients, which is predicted to be one of the most common causes of death internationally.

Increasing Awareness and Government Initiatives

Rising knowledge about the importance of early cancer diagnosis and treatment, as well as public sector proactiveness and allocation of resources to ensure that cancer patients receive high-quality care, are driving the growth of radiation oncology globally. Several public awareness programs and campaigns are being implemented by various non-governmental organizations (NGOs) and international organizations to boost patient awareness of cancer and the rising need for radiation therapy services. Government health agencies are also investing in cancer control, facilities development, and payment schemes to enhance access to radiation services and reduce the cancer burden, which is further driving the radiation oncology market outlook.

Radiation Oncology Industry Segmentation:

Breakup by Type:

  • External Beam Radiation Therapy
  • Linear Accelerators
  • Compact Advanced Radiotherapy Systems
  • Proton Therapy
  • Internal Beam Radiation Therapy
  • Brachytherapy
  • Systemic Beam Radiation Therapy
  • Others

External beam radiation therapy (EBRT) accounts for the majority of the market share

Breakup by Technology:

  • Image-Guided Radiotherapy (IGRT)
  • Intensity Modulated Radiotherapy (IMRT)
  • Stereotactic Technology
  • Proton Beam Therapy
  • 3D Conformal Radiotherapy (3D CRT)
  • Volumetric Modulated Arc Therapy (VMAT)
  • Brachytherapy

Breakup by Application:

  • Prostate Cancer
  • Breast Cancer
  • Lung Cancer
  • Head and Neck Cancer
  • Colorectal Cancer
  • Gynecological Cancer
  • Cervical Cancer
  • Penile Cancer
  • Others

Breakup by End User:

  • Hospitals
  • Cancer Research Institutes
  • Ambulatory and Radiotherapy Centers

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America leads the market, accounting for the largest radiation oncology market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

Key Questions Answered in This Report

  • 1.How big is the radiation oncology market?
  • 2.What is the future outlook of radiation oncology market?
  • 3.What are the key factors driving the radiation oncology market?
  • 4.Which region accounts for the largest radiation oncology market share?
  • 5.Which are the leading companies in the global radiation oncology market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Radiation Oncology Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 External Beam Radiation Therapy
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Linear Accelerators
      • 6.1.2.2 Compact Advanced Radiotherapy Systems
      • 6.1.2.3 Proton Therapy
    • 6.1.3 Market Forecast
  • 6.2 Internal Beam Radiation Therapy
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Brachytherapy
      • 6.2.2.2 Systemic Beam Radiation Therapy
      • 6.2.2.3 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Technology

  • 7.1 Image-Guided Radiotherapy (IGRT)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Intensity Modulated Radiotherapy (IMRT)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Stereotactic Technology
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Proton Beam Therapy
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 3D Conformal Radiotherapy (3D CRT)
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Volumetric Modulated Arc Therapy (VMAT)
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Brachytherapy
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Prostate Cancer
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Breast Cancer
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Lung Cancer
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Head and Neck Cancer
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Colorectal Cancer
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Gynecological Cancer
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Cervical Cancer
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast
  • 8.8 Penile Cancer
    • 8.8.1 Market Trends
    • 8.8.2 Market Forecast
  • 8.9 Others
    • 8.9.1 Market Trends
    • 8.9.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Cancer Research Institutes
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Ambulatory and Radiotherapy Centers
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Accuray Incorporated
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Becton Dickinson and Company
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Canon Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Elekta
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Hitachi Ltd.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Icad Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Ion Beam Applications
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Isoray Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9 Mevion Medical Systems Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Nordion (Canada) Inc. (Sotera Health)
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 SWOT Analysis
    • 15.3.11 P-Cure Ltd.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
    • 15.3.12 Varian Medical Systems Inc. (Siemens Healthineers AG)
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 SWOT Analysis
    • 15.3.13 ViewRay
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials

List of Figures

  • Figure 1: Global: Radiation Oncology Market: Major Drivers and Challenges
  • Figure 2: Global: Radiation Oncology Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Radiation Oncology Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Radiation Oncology Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Radiation Oncology Market: Breakup by Technology (in %), 2024
  • Figure 6: Global: Radiation Oncology Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Radiation Oncology Market: Breakup by End User (in %), 2024
  • Figure 8: Global: Radiation Oncology Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Radiation Oncology (External Beam Radiation Therapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Radiation Oncology (External Beam Radiation Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Radiation Oncology (Internal Beam Radiation Therapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Radiation Oncology (Internal Beam Radiation Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Radiation Oncology (Image-Guided Radiotherapy (IGRT)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Radiation Oncology (Image-Guided Radiotherapy (IGRT)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Radiation Oncology (Intensity Modulated Radiotherapy (IMRT)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Radiation Oncology (Intensity Modulated Radiotherapy (IMRT)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Radiation Oncology (Stereotactic Technology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Radiation Oncology (Stereotactic Technology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Radiation Oncology (Proton Beam Therapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Radiation Oncology (Proton Beam Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Radiation Oncology (3D Conformal Radiotherapy (3D CRT)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Radiation Oncology (3D Conformal Radiotherapy (3D CRT)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Radiation Oncology (Volumetric Modulated Arc Therapy (VMAT)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Radiation Oncology (Volumetric Modulated Arc Therapy (VMAT)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Radiation Oncology (Brachytherapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Radiation Oncology (Brachytherapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Radiation Oncology (Prostate Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Radiation Oncology (Prostate Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Radiation Oncology (Breast Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Radiation Oncology (Breast Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Radiation Oncology (Lung Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Radiation Oncology (Lung Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Radiation Oncology (Head and Neck Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Radiation Oncology (Head and Neck Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Radiation Oncology (Colorectal Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Radiation Oncology (Colorectal Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Global: Radiation Oncology (Gynecological Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Global: Radiation Oncology (Gynecological Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Global: Radiation Oncology (Cervical Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Global: Radiation Oncology (Cervical Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Global: Radiation Oncology (Penile Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Global: Radiation Oncology (Penile Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Global: Radiation Oncology (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Global: Radiation Oncology (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Global: Radiation Oncology (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Global: Radiation Oncology (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Global: Radiation Oncology (Cancer Research Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Global: Radiation Oncology (Cancer Research Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Global: Radiation Oncology (Ambulatory and Radiotherapy Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Global: Radiation Oncology (Ambulatory and Radiotherapy Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: North America: Radiation Oncology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: North America: Radiation Oncology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: United States: Radiation Oncology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: United States: Radiation Oncology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Canada: Radiation Oncology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Canada: Radiation Oncology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Asia-Pacific: Radiation Oncology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Asia-Pacific: Radiation Oncology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: China: Radiation Oncology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: China: Radiation Oncology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Japan: Radiation Oncology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Japan: Radiation Oncology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: India: Radiation Oncology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: India: Radiation Oncology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: South Korea: Radiation Oncology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: South Korea: Radiation Oncology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Australia: Radiation Oncology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Australia: Radiation Oncology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Indonesia: Radiation Oncology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Indonesia: Radiation Oncology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Others: Radiation Oncology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Others: Radiation Oncology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Europe: Radiation Oncology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Europe: Radiation Oncology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Germany: Radiation Oncology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Germany: Radiation Oncology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: France: Radiation Oncology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: France: Radiation Oncology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: United Kingdom: Radiation Oncology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: United Kingdom: Radiation Oncology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Italy: Radiation Oncology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Italy: Radiation Oncology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Spain: Radiation Oncology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Spain: Radiation Oncology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Russia: Radiation Oncology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 86: Russia: Radiation Oncology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 87: Others: Radiation Oncology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 88: Others: Radiation Oncology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 89: Latin America: Radiation Oncology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 90: Latin America: Radiation Oncology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 91: Brazil: Radiation Oncology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 92: Brazil: Radiation Oncology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 93: Mexico: Radiation Oncology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 94: Mexico: Radiation Oncology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 95: Others: Radiation Oncology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 96: Others: Radiation Oncology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 97: Middle East and Africa: Radiation Oncology Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 98: Middle East and Africa: Radiation Oncology Market: Breakup by Country (in %), 2024
  • Figure 99: Middle East and Africa: Radiation Oncology Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 100: Global: Radiation Oncology Industry: SWOT Analysis
  • Figure 101: Global: Radiation Oncology Industry: Value Chain Analysis
  • Figure 102: Global: Radiation Oncology Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Radiation Oncology Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Radiation Oncology Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Radiation Oncology Market Forecast: Breakup by Technology (in Million USD), 2025-2033
  • Table 4: Global: Radiation Oncology Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Radiation Oncology Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 6: Global: Radiation Oncology Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Radiation Oncology Market: Competitive Structure
  • Table 8: Global: Radiation Oncology Market: Key Players